Log In
Print
BCIQ
Print
Print this Print this
 

Methylene Blue MMX (CB-17-01)

  Manage Alerts
Collapse Summary General Information
Company Cosmo Pharmaceuticals S.p.A.
DescriptionOral colon-release formulation of methylene blue delivered using MMX multi-matrix system technology
Molecular Target
Mechanism of ActionDiagnostic
Latest Stage of DevelopmentPhase II
IndicationCancer, Diagnostic
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today